EFTA01374178
EFTA01374179 DataSet-10
EFTA01374180

EFTA01374179.pdf

DataSet-10 1 page 439 words document
P17 V16 D6 D4 V11
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (439 words)
AGP LP 519 Alpha Group Capital Paul Barrett Alke° Capital Management FvkrSson A4enklpti. 20'1' Eton( New York, NY. 10017 Tet: 21271668010 New York I Song Kong- I Boston Dear Investor, Alkeon Growth Partners: Alkeon Growth Alkeon Growth Strategy Strategy Sept. 2017 2017 Since Inception Since Inception (Cumulative) (Annualized) Alkeon Growth Partners 0.47% 26.23% 1225.84%1 13.98%1 MSCI World 2.08% 14.24% 113.60% 3.92% MSCI AC World 1.77% 15.42% 113.66% 3.92% Alkeon Growth Partners Portfolio information (Approximate): • Net Exposure (delta adjusted) 84.7% • Gross Exposure 195% • Number of Long Positions 98 • Number of Short Positions 88 September offered positive results to global equities. Alkeon Growth Partners, LP returned 0.47%. Portfolio performance was positive in the US and Asia and negative in Europe. Our long positions had positive performance during the month while our short positions underperformed. We remain equally constructive on the current global opportunity set for both long and short investments, as we see significant sector-wide discrepancies between valuations and underlying fundamentals. As a result, we believe this is shaping up to be one of the best stock-picking environments since the 2000-01 technology bubble and have maintained a gross exposure at the high-end of our historical range. Furthermore, from a valuation perspective we consider many high quality growth sectors, such as technology and healthcare, to be undervalued and attractive relative to the market. There are three main drivers of portfolio performance so far this year, all of which we believe are likely to be persistent in years to come and favorable to our strategy, as we have detailed in our Q2 letter. One. outperformance of international stocks (for the first year since 2009), two, the beginning stages of valuation multiple renormalization of high quality growth stocks vs. low-growth defensive equity investments (i.e., high quality growth sectors, such as technology and healthcare, should ultimately trade at a premium to the market and especially to low-growth defensive sectors, such as utilities, consumer staples and REITs), and, three, strong fundamental performance ("beat-and-raise" quarterly results) by many high quality classic growth compounders. We believe all of these drivers are likely to persist beyond the short-term and continue to favor our strategy going forward (for reasons we detailed in our Q2 letter). In particular, we believe the fundamental performance of high quality classic growth compounders has the potential to not only persist but also strengthen in light of the upcoming wave of technological innovation (dubbed by many as 'the fourth industrial revolution"), which we believe can be broadly impactful and revolutionary in nature, similar to the internet wave of the CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0068746 CONFIDENTIAL SDNY_GM_00214930 EFTA01374179
ℹ️ Document Details
SHA-256
151190a5aca10a9f7139b5a082b9a780e0336c0b46da6f2c77c1da19b2d20e77
Bates Number
EFTA01374179
Dataset
DataSet-10
Document Type
document
Pages
1

Comments 0

Loading comments…
Link copied!